Skip to content

IMPACT: Improving Motion Precision in Advanced Clinical brain Tumor imaging

IMPACT: Improving Motion Precision in Advanced Clinical brain Tumor imaging - IMPACT

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00036026
Enrollment
72
Registered
2025-02-11
Start date
2025-04-09
Completion date
Unknown
Last updated
2025-10-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

C71.9

Interventions

Group 1: For brain tumor patients, MRI exams are pivotal for diagnosis therapy monitoring. Due to their frequent lack of motion control, we hypothesize that this group will benefit considerably from a

Sponsors

Universitätsklinikum Frankfurt am Main, Goethe Universität
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Suspected (baseline) or diagnosed (follow-up) primary or secondary brain tumors and indication for routine brain MRI.

Exclusion criteria

Exclusion criteria: - Pregnancy - Patients with major contraindications to MR scanning (e.g. presence of implanted MRI-incompatible cardiac devices or insuline pumps). - Factors that may affect their ability to understand and provide informed consent

Design outcomes

Primary

MeasureTime frame
Reduction of motion artifacts on standard MRI sequences in brain tumor patients.

Secondary

MeasureTime frame
1. Reducing the variance of automated brain tumor segmentation through motion correction. 2. Further development of the technology for advanced MRI techniques.

Countries

Germany

Contacts

Public ContactKatharina Wenger-Alakmeh

Universitätsklinikum Frankfurt am Main, Goethe Universität

wenger-alakmeh@med.uni-frankfurt.de+49 (0) 69 6301 80407

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026